Yeon Hee Kim1, Hee Joung Lee1, Jae Eun Shin2, Young Lee2, Jong Chul Shin3, Tae Chul Park1, In Yang Park4. 1. Department of Obstetrics and Gynecology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Republic of Korea. 2. Department of Obstetrics and Gynecology, Yeouido St. Mary's Hospital, The Catholic University of Korea, Republic of Korea. 3. Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, Republic of Korea. 4. Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, Republic of Korea. Electronic address: yoni@catholic.ac.kr.
Abstract
PURPOSE: To identify the correlation between the pre-gravid maternal obesity and the uterine artery pulsatility index (UtA-PI) at 28-34 weeks' gestation, and to evaluate the predictive value of the UtA-PI for the occurrence of adverse outcomes depending on the maternal obesity. METHODS: Between January 2010 and December 2011, 229 pregnant women were prospectively observed and analyzed. The UtA-PI during 28-34 weeks' gestation was estimated, with abnormal UtA-PI defined if the value was above the 95th centile for gestational age. The patients were classified, using a cut-off value for body mass index (BMI) of 25kg/m(2), into obese (pre-gravid BMI≥25kg/m(2)) and non-obese (pre-gravid BMI<25kg/m(2)) groups. We analyzed the association between the pre-gravid BMI and occurrence of abnormal UtA-PI and estimated their contributions to adverse outcomes using regression analyses. RESULTS: The occurrence of abnormal UtA-PI in the women with pre-gravid BMI over 25kg/m(2) was significantly higher than those with normal pre-gravid BMI (OR: 2.49; 95% CI: 1.22-5.12). In multivariate analyses, the combination with abnormal UtA-PI and pre-gravid BMI over 25kg/m(2) contributed to the occurrence of preterm delivery (OR: 33.5; 95% CI: 7.63-147.21), gestational diabetes (OR: 3.98; 95% CI: 1.17-13.56) and pregnancy induced hypertension (OR: 12.71; 95% CI: 3.45-46.87), compared to the control group with pre-gravid BMI of 25kg/m(2) and less, and normal UtA-PI. CONCLUSION: Women with pre-gravid BMI over 25kg/m(2) show increased tendency of abnormal uterine artery pulsatility index during 28-34 weeks, which increases the risk of adverse pregnancy outcomes.
PURPOSE: To identify the correlation between the pre-gravid maternal obesity and the uterine artery pulsatility index (UtA-PI) at 28-34 weeks' gestation, and to evaluate the predictive value of the UtA-PI for the occurrence of adverse outcomes depending on the maternal obesity. METHODS: Between January 2010 and December 2011, 229 pregnant women were prospectively observed and analyzed. The UtA-PI during 28-34 weeks' gestation was estimated, with abnormal UtA-PI defined if the value was above the 95th centile for gestational age. The patients were classified, using a cut-off value for body mass index (BMI) of 25kg/m(2), into obese (pre-gravid BMI≥25kg/m(2)) and non-obese (pre-gravid BMI<25kg/m(2)) groups. We analyzed the association between the pre-gravid BMI and occurrence of abnormal UtA-PI and estimated their contributions to adverse outcomes using regression analyses. RESULTS: The occurrence of abnormal UtA-PI in the women with pre-gravid BMI over 25kg/m(2) was significantly higher than those with normal pre-gravid BMI (OR: 2.49; 95% CI: 1.22-5.12). In multivariate analyses, the combination with abnormal UtA-PI and pre-gravid BMI over 25kg/m(2) contributed to the occurrence of preterm delivery (OR: 33.5; 95% CI: 7.63-147.21), gestational diabetes (OR: 3.98; 95% CI: 1.17-13.56) and pregnancy induced hypertension (OR: 12.71; 95% CI: 3.45-46.87), compared to the control group with pre-gravid BMI of 25kg/m(2) and less, and normal UtA-PI. CONCLUSION:Women with pre-gravid BMI over 25kg/m(2) show increased tendency of abnormal uterine artery pulsatility index during 28-34 weeks, which increases the risk of adverse pregnancy outcomes.
Authors: Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson Journal: Am J Physiol Endocrinol Metab Date: 2018-03-06 Impact factor: 4.310
Authors: Antonia Hufnagel; Denise S Fernandez-Twinn; Heather L Blackmore; Thomas J Ashmore; Robert A Heaton; Benjamin Jenkins; Albert Koulman; Iain P Hargreaves; Catherine E Aiken; Susan E Ozanne Journal: J Physiol Date: 2021-09-29 Impact factor: 6.228